Indications
Theralugand is a radiopharmaceutical precursor, and it is not intended for direct use in patients. It is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177Lu) chloride.
Composition
- Active substance
- lutetium (177Lu) chloride
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Theralugand
- Active substance
- lutetium (177Lu) chloride
- ATC code
- V10X
- Group
- Various
- Therapeutic area
- Radionuclide Imaging
- Marketing authorisation holder
- Eckert & Ziegler Radiopharma GmbH
- Status